Pancreatic Cancer Research

ResearcherIndiana University IndianapolisActive in the last 2 years

Sanya Haiaty

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1784-4926; OpenAlex author ID A5020836552. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Beyond Cys65: Redox Effector Factor-1 CRISPR-Engineered Cys93 and Cys99 Mutants Reveal Cooperative and Secondary Roles of Redox Signaling and Pancreatic Ductal… Co-author DOI 10.1177/15230864261489484↗
  2. Targeting APE1 endonuclease activity impairs metastasis and enhances genotoxic therapy response in pancreatic cancer. Co-author DOI 10.1186/s13046-026-03705-7↗
  3. The absence of Peroxiredoxin-1 in human pancreatic ductal adenocarcinoma (PDAC) markedly reduces cell survival and tumor growth when coupled with the inhibitio… Co-author DOI 10.1016/j.redox.2025.103848↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Melissa L. Fishel · 3 shared papers, 2025–2026 · strength 0.74
  2. Mark R. Kelley · 3 shared papers, 2025–2026 · strength 0.74
  3. Mahmut Mijit · 2 shared papers, 2026 · strength 0.51
  4. Silpa Gampala · 2 shared papers, 2026 · strength 0.51
  5. Eyram K. Kpenu · 2 shared papers, 2026 · strength 0.51
  6. Rajesh Sardar · 2 shared papers, 2026 · strength 0.51
  7. Sonia Kiran · 1 shared paper, 2025 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.